Conference Details - Agenda

View all Conferences

Continuing Education Information

Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credit™

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.

Eighth International Congress on Targeted Therapies in Cancer

Renaissance Mayflower Hotel
Washington, DC
August 21-23, 2009

Friday, Aug 21, 2009

7:30 am Registration and Continental Breakfast
8:00 am Welcome, Introduction, and Presession Survey
Keynote Lecture
8:10 am Personalizing Therapy for Triple-Negative Breast Cancer
Greg Finak
8:40 am Question-and-Answer Session
Targeting the Tumor Microenvironment
8:45 am Overview of Tumor Hypoxia
Elizabeth A. Repasky
9:10 am Question-and-Answer Session
9:15 am HIF1α Inhibitors
Giovanni Melillo
9:40 am Question-and-Answer Session
9:45 am Blocking Fibroblast Growth Factor Activity
Anthony Tolcher
10:10 am Question-and-Answer Session
10:15 am Break
10:30 am c-Met Inhibitors
Anthony Tolcher
10:55 am Question-and-Answer Session
11:00 am Vascular Disrupting Agents
Alex Adjei
11:25 am Question-and-Answer Session
11:30 am Postsession Questions and Panel Discussion
11:50 am Lunch
Emerging Approaches in Cancer Therapy
12:50 pm Presession Questions
1:00 pm The Cancer Genome Project
Robert J. Penny
1:25 pm Question-and-Answer Session
1:30 pm Potential of MicroRNAs in Cancer Therapy
Sai Yendamuri
1:55 pm Question-and-Answer Session
2:00 pm Biomarkers to Predict Toxicity
Alex Adjei
2:25 pm Question-and-Answer Session
2:30 pm Postsession Questions and Panel Discussion
2:50 pm Adjourn
Workshop - Drug Discovery Platforms and Novel Agents (This session is open to industry speakers; Non-CME)
3:00 pm-4:30 pm Pim1 Inhibitors
Wen Wee Ma
  Targeting ALK
Stephan W. Morris
  LOX 1/2 Inhibitors
Peter Van Vlasselaer
  Blocking XIAP Function
John W. Gillard
  Multitargeted Kinase Inhibitors
Grace K. Dy
  Immunoglobulin Engineering: Rationales and Approaches
Louis M. Weiner

Educational Grants

An educational grant for this activity was provided by:


  1. Genentech BioOncology
  3. Amgen
  4. Merck Oncology
  5. sanofi-aventis U.S.
  6. Wyeth Pharmaceuticals
  8. Novartis Oncology
  10. ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
  11. OSI Oncology